30 GY IN 4 STEREOTACTIC BODY RADIOTHERAPY (SBRT) FRACTIONS FOR COMPLEX SPINAL METASTASES: MATURE OUTCOMES SUPPORTING THIS NOVEL REGIMEN

نویسندگان

چکیده

Abstract We designed a 30 Gy in 4 fractions stereotactic body radiotherapy (SBRT) protocol, as an alternative option to our standard 2-fraction approach, for primarily large volume, multilevel, or previously radiated spinal metastases. report imaging-based outcomes of this novel fractionation scheme. MATERIALS AND METHODS: Retrospective analysis all patients who underwent Gy/4 from 2010-2021 identified institutional database. Primary were magnetic resonance-based vertebral compression fracture (VCF) and local failure (LF). RESULTS: reviewed 245 treated segments 116 patients. The median number consecutive within the treatment volume was 2 (range, 1-6) clinical target (CTV) 126.2 cc 10.4-863.5). Fifty-four percent had received at least one prior course radiotherapy. cumulative incidence LF 10.7% (95% CI 7.1-15.2) 1 year 16% 11.5-21.2) years. VCF 7.3% 4.4-11.2) 11.2% 7.5-15.8) On multivariable analysis, age ≥68 years (p=0.038), CTV ≥72 (p=0.021), no surgery (p=0.021) predicted VCF. risk volumes <72 cc/≥72 1.8%/14.6% No case radiation-induced myelopathy observed. CONCLUSION: safe efficacious despite population increased toxicity. lower stabilized highlights potential multi-modal approach complex metastases, especially those with cc.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases

BACKGROUND AND PURPOSE Radiotherapy of central lung tumors carries a higher risk of treatment-related toxicity and local failure. In the era of aggressive oligometastic management the exploration of the proper dose-fractionation for metastatic central lung tumors is essential. MATERIALS AND METHODS Patients diagnosed with high-risk metastatic lesions of the central pulmonary tree comprised th...

متن کامل

Stereotactic body radiotherapy for spinal and bone metastases.

Stereotactic body radiotherapy (SBRT) can deliver high radiation doses to small volumes with very tight margins, which has significant advantages when treating tumours close to the spinal cord or at sites of retreatment. When treating spinal tumours, meticulous quality control is essential with effective immobilisation, as dose gradients at the edge of the spinal cord will be steep and excessiv...

متن کامل

Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma

PURPOSE To investigate the outcomes of patients with spinal metastases from hepatocellular carcinoma (HCC), who were treated by stereotactic body radiotherapy (SBRT). MATERIALS AND METHODS This retrospective study evaluated 23 patients who underwent SBRT from October 2008 to August 2012 for 36 spinal metastases from HCC. SBRT consisted of approximately 2 fractionation schedules, which were 18...

متن کامل

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

BACKGROUND In limited metastatic burden of disease, stereotactic body radiotherapy (SBRT) has been shown to achieve high local control rates. It has been hypothesized that SBRT may translate to a better quality of life by delaying the need for systemic chemotherapy and possibly increasing survival. There is limited published literature on the efficacy of SBRT in limited nodal metastases. The pr...

متن کامل

Timely stereotactic body radiotherapy (SBRT) for spine metastases using a rapidly deployable automated planning algorithm

PURPOSE/OBJECTIVES The complex planning and quality assurance required for spine SBRT are a barrier to implementation in time-sensitive or limited resource clinical situations. We developed and validated an automated inverse planning algorithm designed to streamline planning and allow rapid delivery of conformal single fraction spine SBRT using widely available technology. MATERIALS/METHODS T...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Neuro-oncology advances

سال: 2023

ISSN: ['2632-2498']

DOI: https://doi.org/10.1093/noajnl/vdad071.028